Method for preparing lactic acid bacteria culture, product thereof and culture medium
By culturing lactic acid bacteria in the culture medium contained in heme protein under ventilation, the problem of using non-vegetarian heme sources in the prior art is solved, and efficient and economical lactic acid bacteria culture production is achieved, suitable for vegetarian food, feed and medicines , simplifies the processing process.
Patent Information
- Application Number
- CN202380025405.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-03-04
- Filing Date
- 2023-03-03
- Publication Date
- 2024-11-26
AI Technical Summary
The use of non-vegetarian-compliant heme sources in existing lactic acid bacterial culture production methods has resulted in the inability to apply to vegetarian foods, feeds and medicines, and the difficulty in producing, processing and purifying yeast cells, increasing costs and processing steps.
Cultivate microbial strains, such as lactic acid bacteria in a culture medium containing heme protein under ventilation, obtain fermentation and harvest microbial cultures, and use heme protein as a vegetarian compliant alternative source of heme to support the respiration of microbial strains, achieving Similar yields to existing methods.
Provides a lactic acid bacteria culture for the manufacture of vegetarian, feed and medicines, achieving yields similar to existing methods, while avoiding the use of non-vegetarian compliant heme sources, reducing production costs and simplifying processing step.
Smart Images

Figure CN119032163A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of microbial starter cultures. More specifically, the present invention provides a method for preparing a microbial starter culture under ventilation. The microbial starter culture can be a lactic acid bacteria (LAB) starter culture, wherein the lactic acid bacteria are inoculated in a culture medium, and wherein the culture medium contains at least one heme protein. This new method uses raw materials that meet the requirements of vegetarian regulations. Therefore, the starter culture obtained by the new method can be used to prepare vegetarian food, feed and medicine. Technical Background
[0002] Microbial cultures are widely used in the manufacture of fermented products in food, feed and pharmaceutical industries, including most dairy products, such as cheese, yogurt and butter, and also for meat, baked goods, wine or vegetable products. In addition, microbial cultures are also used to produce proteins and various useful compounds including enzymes. Such microbial cultures are commonly referred to as starter cultures, which are produced and distributed to the fermentation industry by industrial breeding factories, such as dairy factories, where starter cultures are used in their production processes. Especially, the culture of lactic acid bacteria is widely used as starter cultures.
[0003] The production of lactic acid bacteria (LAB) starter cultures involves inoculating LAB cells in a specific fermentation medium and propagating an appropriate number of cells under appropriate fermentation conditions. In an industrial setting, a lot of effort needs to be invested to obtain a high concentration of propagating cells at the end of the fermentation process. The fermentation conditions and the fermentation medium must support the growth of the cells in order to obtain the desired high biomass yield.
[0004] The methods currently applied for producing starter cultures of lactic acid bacteria, such as Lactococcus lactis starter cultures, apply non-vegetarian compliant sources as raw materials in the fermentation medium. The non-vegetarian compliant sources are applied as exogenous sources. The exogenous source can be a heme source, and it is added to support the respiratory process of the lactic acid bacteria. Due to the use of non-vegetarian compliant heme sources, such starter cultures obtained by known methods cannot be applied in vegetarian foods, feeds and pharmaceuticals. Therefore, there is a need in the art to develop a respiratory method for producing microbial starter cultures, such as lactic acid bacteria, which has a yield similar to that of methods known in the art, and wherein the method applies a vegetarian compliant heme source.
[0005] Yeast cells have been used as a vegetarian-compliant heme source, as disclosed in WO2021 / 116311A1. However, yeast cells are difficult to produce, handle and purify, which can result in increased costs. Yeast cells increase dry matter in addition to LAB biomass. Using yeast cell-based materials in the form of yeast extracts would add additional processing steps to the preparation of materials containing heme proteins. Summary of the invention
[0006] The problem to be solved by the present invention is to provide a microbial culture, such as a lactic acid bacteria culture suitable for producing vegetarian food, feed and medicine.
[0007] Therefore, a first aspect of the present invention relates to a method for obtaining a microbial culture, the method comprising the following steps:
[0008] (i) cultivating at least one microbial strain in a culture medium under aeration and obtaining a fermentation product,
[0009] (ii) harvesting the at least one microbial strain from the fermentation to obtain a microbial culture,
[0010] wherein the culture medium comprises at least one heme protein.
[0011] In a second aspect, the invention relates to a culture obtainable by the method of the invention.
[0012] In a third aspect, the invention relates to a culture comprising at least one heme protein.
[0013] A fourth aspect of the invention relates to a culture medium comprising at least one heme protein.
[0014] A fifth aspect of the present invention relates to a method for preparing a food, feed product, pharmaceutical, dairy flavoring and cheese flavoring product, the method comprising adding an effective amount of the culture of the present invention to a food, feed or pharmaceutical starting material and maintaining the inoculated culture under conditions where at least one microbial strain is metabolically active.
[0015] A sixth aspect of the present invention relates to a fermented food, feed or pharmaceutical product obtainable by the method of the present invention.
[0016] A seventh aspect of the present invention relates to the use of at least one heme protein in a fermentation method and / or a fermentation process.
[0017] An eighth aspect of the invention relates to a food, feed product, pharmaceutical product, dairy flavouring or cheese flavouring product comprising the culture according to the second or third aspect. DETAILED DESCRIPTION
[0018] The present inventors have developed a method for obtaining a microbial culture, such as a starter culture of a microbial strain, such as a lactic acid bacteria, wherein a heme protein is used as an alternative heme source that is vegetarian compliant instead of a non-vegetarian compliant heme source. The use of the heme protein as an exogenous heme source was unexpectedly shown to support respiration of the microbial strain, such as a lactic acid bacteria. The purified heme protein is a vegetarian compliant raw material. The method provides a yield comparable to methods known in the art.
[0019] Before discussing detailed embodiments of the present invention, further definitions of selected terms used herein are provided.
[0020] As used herein, the term "fermentation" refers to the process of propagating or culturing microbial cells under aerobic or anaerobic conditions.
[0021] The term "starter culture" refers to a preparation comprising microbial cells intended to be inoculated into a medium to be fermented.
[0022] In this context, the term "yield" refers to the amount of biomass produced in a given volume of fermentation. Yield can be measured in various ways; in this article, yield is measured in two different ways. 1) The optical density (OD) of the fermentation medium at 600 nm with a pathlength of 1 cm at the end of the fermentation. 600 ) measured as biomass per unit volume (minus background); 2) "acidification activity" or acidification capacity of 4.8-5.2 as determined by the Pearce test, expressed as kg of F-DVS culture at the end of fermentation; 3) by the packed cell volume (PCV) test, or; 4) cell count.
[0023] The term "F-DVS" refers to the so-called frozen direct-dive cultures described in the Examples.
[0024] The legal framework for vegetarian claims in Europe is currently under revision and there are no harmonized rules. All claims under European food legislation, vegan and vegetarian claims are any information or representation, not mandatory under EU or national legislation, including any form of pictorial, graphic or symbolic representation, which indicates, suggests or implies that a food has a specific characteristic (Neli Sochirca (2018), EFFL, 6, p. 514). Therefore, in this article, the term "vegetarian compliant heme source" refers to a heme source that is not obtained or derived from animals and / or multicellular organisms. In contrast, the term "non-vegetarian compliant heme source" refers to a heme source that is obtained or derived from animals and / or multicellular structures.
[0025] In one embodiment of the present invention, one or more microbial strains are microbial strains that cannot grow by respiration without supplementing components / alternative components of the respiratory chain. It should be understood that supplementation of components / alternative components of the respiratory chain can be supplementation of an exogenous heme source.
[0026] The at least one microbial strain may be selected from the group consisting of: Lactococcus, Streptococcus, Lactobacillus (now known as Ligilactobacillus), Holzapfelia, Amylolactobacillus, Bombilactobacillus, Companilactobacillus, Lapidilactobacillus, Agrilactobacillus, Schleiferilactobacillus, Loigolactobacilus, Lacticaseibacillus, Latilacto bacillus, Dellaglioa, Liquidilactobacillus, Lactiplantibacillus, Furfurilactobacillus, Paucilactobacillus, Limosilactobacillus, Fructilactobacillus, Acetilactobacillus, Apilactobacillus, Levilactobacillus, Secundilactobacillus, and Lentilactobacillus (e.g., Zheng et al., Int. J. Syst. Evol. Microbiol. DOI: 10.1016 / 0300-9444-0100). 10.1099 / ijsem.0.004107), Leuconostoc, Oenococcus, Weissella, Pediococcus, Enterococcus, Bifidobacterium, Brevibacterium, Propionibacterium, and combinations thereof.Most genera in this group are "lactic acid bacteria", however, an industrially important genus is Bifidobacterium, which, although phylogenetically unrelated, is sometimes included in the lactic acid bacteria group because lactic acid is one of its major fermentation end products. The list also includes other industrially important starter cultures not included in the lactic acid bacteria genera belonging to the genera Brevibacterium and Propionibacterium.
[0027] As used herein, the term "lactic acid bacteria" (LAB) refers to Gram-positive, microaerophilic or anaerobic bacteria that ferment sugars and produce acids, including lactic acid (as the major acid produced) and acetic acid. The most industrially useful lactic acid bacteria are found in the following genera: Lactococcus, Streptococcus, Lactobacillus (now called Ligilactobacillus), Holzapfelia, Amylolactobacillus, Bombilactobacillus, Companilactobacillus, Lapidilactobacillus, Agrilactobacillus, Schleiferilactobacillus, Loigolactobacilus, Lacticaseibacillus, Latilactobacillus, Delaglio Dellaglioa, Liquidilactobacillus, Ligilactobacillus, Lactiplantibacillus, Furfurilactobacillus, Paucilactobacillus, Limosilactobacillus, Fructilactobacillus, Acetilactobacillus, Apilactobacillus, Levilactobacillus, Secundilactobacillus, and Lentilactobacillus (e.g., Zheng et al., Int. J. Syst. Evol. Microbiol. DOI: 10.1016 / 000400-010-0100-1). 10.1099 / ijsem.0.004107), Leuconostoc, Oenococcus, Weissella, Pediococcus, and Enterococcus.As mentioned above, another industrially important genus is Bifidobacterium, which, although phylogenetically unrelated, is sometimes included in the lactic acid bacteria group because lactic acid is one of its major fermentation end products.
[0028] Thus, in one embodiment, at least one microbial strain is a lactic acid bacterium selected from the group consisting of Lactococcus, Streptococcus, Lactobacillus (now known as Ligilactobacillus), Holzapfelia, Amylolactobacillus, Bombilactobacillus, Companilactobacillus, Lapidilactobacillus, Agrilactobacillus, Schleiferilactobacillus, Loigolactobacilus, Lacticaseibacillus, Lapidolactobacillus, Lactobacillus spp. tilactobacillus), Dellaglioa, Liquidilactobacillus, Lactiplantibacillus, Furfurilactobacillus, Paucilactobacillus, Limosilactobacillus, Fructilactobacillus, Acetilactobacillus, Apilactobacillus, Levilactobacillus, Secundilactobacillus, and Lentilactobacillus (e.g., Zheng et al., Int. J. Syst. Evol. Microbiol. DOI: 10.1016 / 0300-9444-0100). 10.1099 / ijsem.0.004107), Leuconostoc, Oenococcus, Weissella, Pediococcus, Enterococcus, Bifidobacterium, and combinations thereof.
[0029] Commonly used lactic acid bacteria starter culture strains are generally divided into mesophilic organisms having an optimum growth temperature of about 30°C and thermophilic organisms having an optimum growth temperature in the range of about 40 to about 45°C.
[0030] It should be understood that the Lactobacillus taxonomy was updated in 2020. The new taxonomy was disclosed in Zheng et al. 2020 and those important to the present invention are summarized as follows:
[0031]
[0032] Typical organisms belong to the group comprising: Lactococcus lactis, Lactococcus lactis subsp. cremoris, Leuconostoc mesenteroides subsp. cremoris, Pediococcus pentosaceus, Lactococcus lactis subsp. lactis biovar. diacetylactis, Lactobacillus casei subsp. casei (Lactobacillus casei) and Lactobacillus paracasei subsp. casei (Lactobacillus paracasei and Lactobacillus paracasei tolerogenic). Thermophilic lactic acid bacteria species include, for example, Streptococcus thermophilus, Enterococcus faecium, Lactobacillus delbrueckii subsp. lactis, Lactobacillus helveticus, Lactobacillus delbrueckii subsp. bulgaricus, and Lactobacillus acidophilus.
[0033] Since the amount and concentration of heme proteins, lactic acid bacteria, heme proteins or any other nutrient in the culture medium may change over time, for example, due to incorporation into microbial cells, it is necessary to refer to a specific time point at which the concentration of the heme proteins must be measured or determined. Therefore, when used in conjunction with the concentration of heme proteins, lactic acid bacteria, heme proteins or any other nutrient in the culture medium, the terms "initially" or "pre-fermentation" (also used interchangeably herein) are the concentrations of heme proteins, lactic acid bacteria, heme proteins or any other nutrient present in the culture medium before the microbial cells to be cultured are added to the culture medium.
[0034] However, the heme protein can also be added at any time before harvest for the entire fermentation process. The addition of the heme protein can be done batchwise or continuously. Therefore, an important metric is the "total amount added" during the entire fermentation process.
[0035] An important application of the starter culture according to the invention is as so-called probiotics. In this context, the term "probiotics" is understood to mean microbial cultures which, when ingested in the form of living cells by humans or animals, improve health conditions, for example by inhibiting harmful microorganisms in the gastrointestinal tract, strengthening the immune system or aiding the digestion of nutrients. A typical example of such a probiotic active product is "sweet acidophilus milk".
[0036] The listing or discussion of an apparently prior-published document in this specification should not necessarily be taken as an admission that the document is part of the prior art or is common general knowledge.
[0037] Unless the context indicates otherwise, the embodiments, preferences and options of a given aspect, feature or parameter of the present invention should be considered to have been disclosed in combination with any and all embodiments, preferences and options of all other aspects, embodiments, features and parameters of the present invention. For example, embodiments related to lactic acid bacteria cultures obtainable by the method of the present invention may be equally applicable to lactic acid bacteria starter cultures. Moreover, the embodiments related to the method of the present invention may be related to the product of the present invention, and vice versa.
[0038] Embodiments of the invention are described below by way of example only.
[0039] One aspect of the present invention relates to a method for obtaining a microbial culture, the method comprising the following steps:
[0040] (i) cultivating at least one microbial strain in a culture medium under aeration and obtaining a fermentation product,
[0041] (ii) harvesting the microbial strain from the fermentation to obtain a microbial culture,
[0042] wherein the culture medium comprises at least one heme protein.
[0043] In an embodiment, the present invention relates to a method for obtaining a lactic acid bacteria culture, the method comprising the following steps:
[0044] (i) cultivating at least one lactic acid bacteria culture in a culture medium under aeration and obtaining a fermentation product,
[0045] (ii) harvesting the microbial strain from the fermentation to obtain a microbial culture,
[0046] wherein the culture medium comprises at least one heme protein.
[0047] In one embodiment, the method of the present invention may further comprise the following steps:
[0048] (iii) concentrating the microbial culture to obtain a concentrated microbial culture.
[0049] In one embodiment, the method of the present invention may further comprise the following steps:
[0050] (iii) concentrating the lactic acid bacteria culture to obtain concentrated lactic acid bacteria.
[0051] The concentration may be carried out using methods known in the art, such as but not limited to centrifugation or ultrafiltration. In order to obtain an increased number of microorganisms (e.g. lactic acid bacteria) in the concentrate obtained in step (iii), it is contemplated that the concentration factor in step (iv) is in the range of 2 to 20, such as in the range of 6-19, such as in the range of 7-18, such as 8-17, such as 9-16, such as 10-15, such as 11-14, such as 12-13, such as 2-4, such as 3-6.
[0052] Commercial starter cultures are often distributed as frozen cultures. At the low temperatures at which such frozen cultures are typically maintained, most metabolic activity in the cells ceases, and the cells can be maintained in this suspended but viable state for extended periods of time.
[0053] Concentrated frozen cultures are very attractive commercially because they can be directly inoculated into production vessels. By using such concentrated frozen cultures, the end user avoids the otherwise necessary and time-consuming intermediate fermentation step during which the starter culture is expanded; and the end user also greatly reduces the risk of contamination. Such concentrated cultures may be referred to as DVS direct inoculations. TM Culture.
[0054] As an alternative to concentrated frozen cultures, concentrated freeze-dried direct-injection cultures can be prepared. TM Culture, FD-DVS TM Such cultures have the added advantage that they can be transported without refrigeration.
[0055] Therefore, in an embodiment, the method of the present invention may further comprise the following steps:
[0056] (iv) freezing the microbial bacterial culture in step (ii) or the concentrated microbial culture in step (iii) to obtain a frozen microbial culture.
[0057] Therefore, in an embodiment, the method of the present invention may further comprise the following steps:
[0058] (iv) freezing the lactic acid bacteria culture in step (ii) or the concentrated lactic acid bacteria in step (iii) to obtain a frozen lactic acid bacteria culture.
[0059] In order to remove liquid from the frozen microbial bacterial culture, the method of the present invention may further comprise the following steps:
[0060] (v) sublimating water from the frozen microorganism culture to obtain a dried microorganism culture.
[0061] In order to remove liquid from the frozen lactic acid bacteria culture, the method of the present invention may further comprise the following steps:
[0062] (v) sublimating water from the frozen lactic acid bacteria culture to obtain a dried lactic acid bacteria culture.
[0063] Step (v) may be performed by a technique selected from the group consisting of spray drying, spray freezing, vacuum drying, air drying, freeze drying, tray drying and vacuum tray drying.
[0064] In another embodiment, the method of the present invention further comprises the following steps:
[0065] (vii) packaging the frozen microbial culture obtained in step (iv) or the freeze-dried microbial culture obtained in step (v).
[0066] It is understood that the method of the present invention further comprises the following steps:
[0067] (vii) packaging the frozen lactic acid bacteria culture obtained in step (iv) or the dried lactic acid bacteria culture obtained in step (v).
[0068] Destructive effects of freezing and thawing on viability of living cells have been frequently observed. Generally, they are attributed to cellular dehydration and the formation of ice crystals in the cell cytosol during freezing.
[0069] However, a variety of cryoprotectants have been found to ensure that freezing occurs in a controlled and minimally damaging manner, for example by ensuring that ice crystallization in the cell cytosol is prevented or minimized during the freezing process.
[0070] Preferably, at least one cryoprotectant is added to the harvested microbial culture or the harvested lactic acid bacteria culture obtained in step (ii), or to the concentrated microbial culture or the concentrated lactic acid bacteria culture obtained in step (iii).
[0071] Preferably, cryoprotectants are selected from the group consisting of: one or more compounds involved in nucleic acid biosynthesis or one or more derivatives of any such compounds. Examples of preferred one or more cryoprotectants suitable for addition to the microorganisms harvested correspond substantially to preferred one or more heme proteins described herein. In the patent application for application number PCT / DK2004 / 000477 submitted earlier, such one or more cryoprotectants are added to the microorganisms harvested. The preferred one or more cryoprotectants described in PCT / DK2004 / 000477 are also preferred one or more cryoprotectants of the present invention. The complete description of PCT / DK2004 / 000477 is incorporated herein by reference. In another preferred embodiment of the present invention, one or more cryoprotectants are selected from nucleoside monophosphates. In a preferred embodiment, at least one or the only cryoprotectant is IMP. In general, carbohydrate or protein type cryoprotectants are not described as increasing the metabolic activity of thawing or reconstructing cultures. When cultures are inoculated into a culture medium to be fermented, processed or converted, cryoprotectants of the present invention can also impart increased metabolic activity (enhancing effect) to cultures in addition to their cryoprotective activity. Therefore, one embodiment of the present invention is a frozen or dried culture, wherein the cryoprotectant is a mixture of reagents or reagents, which has an enhancing effect in addition to its cryoprotective properties. The expression "enhancing effect" is used to describe such a situation, wherein when the thawed or reconstructed culture is inoculated into a culture medium to be fermented or converted, the cryoprotectant imparts an increased metabolic activity (enhancing effect) to the thawed or reconstructed culture. Vitality and metabolic activity are not synonymous. Commercial freezing or drying (e.g., freeze-drying) cultures can retain their vitality, although they may have lost a large part of metabolic activity, such as even if the storage time is short, the culture may also lose acid production (acidification) activity. Therefore, vitality and enhancing effect must be evaluated by different assays. Although vitality is evaluated by vitality assays (e.g., determining colony forming units), the enhancing effect is evaluated by quantifying the metabolic activity of the thawed or reconstructed culture relative to the vitality of the culture.
[0072] The acidification activity assay described below is one example of an assay to quantify relevant metabolic activity of thawed or reconstituted cultures.
[0073] Although acidogenic activity is exemplified herein, the present invention is intended to encompass stabilization of any type of metabolic activity of the culture. Thus, the term "metabolic activity" refers to the deoxygenation activity of the culture, its acidogenic activity (i.e., production of, for example, lactic acid, acetic acid, formic acid and / or propionic acid), or its metabolite-producing activity (e.g., production of aromatic compounds such as acetaldehyde (α-acetolactate, acetoin, diacetyl, and 2,3-butanediol (butanediol)).
[0074] In embodiments of the present invention, the frozen culture contains or comprises 0.2% to 20% cryoprotectant or reagent mixture, measured as % w / w of the frozen material. However, the amount of cryoprotectant or reagent mixture preferably added is in the range of 0.2% to 15%, more preferably in the range of 0.2% to 10%, more preferably in the range of 0.5% to 7%, more preferably in the range of 1% to 6% (including within the range of 2% to 5% cryoprotectant or reagent mixture measured as % w / w of the weight of the frozen material). In preferred embodiments, the culture comprises about 3% cryoprotectant or reagent mixture, measured as % w / w of the weight of the frozen material. The preferred amount of about 3% cryoprotectant corresponds to a concentration within the range of 100mM. It should be appreciated that for each aspect of the embodiments of the present invention, these ranges can be increments of the described ranges.
[0075] Where the culture is a dried culture (e.g. freeze dried), the amount of cryoprotectant or reagent mixture added is preferably in the range of 0.8% to 60% by weight of the dried culture, or in the range of 0.8% to 55% by weight, or in the range of 1.3% to 40% by weight, or in the range of 3% to 30% by weight, or in the range of 6% to 25% by weight, including the range of 10% to 24% by weight. In preferred embodiments, the dried (e.g. freeze dried) culture comprises about 16% cryoprotectant or reagent mixture, measured as % w / w of the dried culture.
[0076] In addition, the frozen or dried culture may further contain conventional additives, including nutrients such as yeast extract, sugars, antioxidants, inert gases, vitamins, and the like. Surfactants of the compound may also be used as further additives to the culture according to the invention. Other examples of such conventional additives that may additionally be added to the culture according to the invention may be selected from proteins, protein hydrolysates and amino acids. Preferred suitable examples of these include those selected from the group consisting of glutamic acid, lysine, sodium glutamate, sodium caseinate, malt extract, skimmed milk powder, whey powder, yeast extract, gluten, collagen, gelatin, elastin, keratin, and albumin or mixtures thereof.
[0077] More preferably, conventional additives are carbohydrates. Suitable examples of these include those selected from the group consisting of: pentoses (e.g., ribose, xylose), hexoses (e.g., fructose, mannose, sorbose), disaccharides (e.g., sucrose, trehalose, melibiose, lactulose), oligosaccharides (e.g., raffinose), oligofructose (e.g., Actilight, Fribroloses), polysaccharides (e.g., maltodextrin, xanthan gum, pectin, alginate, microcrystalline cellulose, dextran, PEG) and sugar alcohols (sorbitol, mannitol and inositol).
[0078] It is currently preferred that the ratio (wt% / wt%) of at least one cryoprotectant to the concentrated microbial culture or concentrated lactic acid bacteria culture is in the range of 1:0.5 to 1:5, such as 1:1 to 1:4 or 1:1. 1 / 2 to 1:3.
[0079] An alternative embodiment of the present invention is a method for preparing the microbial culture described herein with increased yield, and the method further comprises drying the concentrated microbial culture or concentrated lactic acid bacteria culture obtained in step (iii) by freeze drying, tray drying, spray drying, spray freezing, vacuum drying, air drying or any drying process suitable for drying bacterial cultures.
[0080] The at least one heme protein may be present in the culture medium or added to the culture medium before adding the at least one microbial strain and / or lactic acid bacteria to the culture medium, or alternatively, the at least one heme protein may be added immediately after adding the at least one microbial strain and / or lactic acid bacteria to the culture medium.
[0081] In one embodiment, at least one heme protein is a protein with native biocatalytic activity. In a preferred embodiment, the heme protein is an enzyme, such as a catalase or a peroxidase. In a particularly preferred embodiment, the heme protein is a catalase, such as, but not limited to,
[0082] In one embodiment, at least one heme protein having native biocatalytic activity has been inactivated. A variety of inactivation methods can be used to achieve the purpose of inactivating the native biocatalytic activity, such as pH (alkaline) inactivation, enzyme digestion or heat inactivation. In a preferred embodiment, the inactivation is heat inactivation. Heat inactivation can be performed by any method known in the art, such as but not limited to autoclaving and / or UHT.
[0083] The inventors unexpectedly found that the addition of a thermostable compound enables industrial processing of heme proteins while enabling high growth yields. In one embodiment, the culture medium further comprises a thermostable compound selected from the group consisting of a polyol, a sugar, a biopolymer, an amino acid, a salt, a polymer and a non-ionic detergent. The heat stable compound can be selected from the group consisting of: sorbitol, glycerol, propylene glycol, mannitol, xylitol, propanediol, trehalose, sucrose, lactose, maltose, glucose, fructan (fructose homopolysaccharide), dextran, dextran sulfate, gelatin (type A and type B), hydroxyethyl starch, poly-L-glutamic acid, poly-L-lysine, fucoidan, pentosan polysulfate, keratan sulfate, polyaspartate, polyglutamate, hydroxyethylcellulose, hydroxypropyl-β-cyclodextrin, glycine, L-arginine hydrochloride, arginine, proline, lysine, histidine, aspartic acid, glutamic acid, acetate, citrate, sodium chloride, phosphate, ascorbate, polyacrylic acid randomly modified with n-octylamine and isopropylamine (A8-35), polyethylene glycol (PEG), polyvinyl sulfate, polysorbate 20, polysorbate 80, Triton X-100, Pluronic F68, Pluronic F88, Pluoronic F-127, Brij 35 (polyoxyethylene alkyl ether). In a preferred embodiment, the heat stabilizing compound is sorbitol.
[0084] In one embodiment, the heme protein is a protein that has no native biological activity.
[0085] In one embodiment, the heme protein is produced by a microorganism. In one embodiment, the heme protein is indirectly derived from Aspergillus niger or is directly produced by Aspergillus niger. In one embodiment, the heme protein is indirectly derived from Pichia pastoris or is directly produced by Pichia pastoris. In one embodiment, the heme protein is indirectly derived from Escherichia coli or is directly produced by Escherichia coli. In one embodiment, the heme protein is indirectly derived from Bacillus or is directly produced by Bacillus.
[0086] At least one heme protein is added to or present in the culture medium as a raw material intended to aid fermentation. The inventors have surprisingly found that the use of non-vegetarian sources in the culture medium can be replaced by at least one heme protein without reducing the yield.
[0087] Therefore, one aspect of the present invention relates to the use of at least one heme protein in a fermentation method and / or a fermentation process.
[0088] The culture medium may be a complex fermentation medium.
[0089] The complex fermentation medium may be any complex fermentation medium known in the art, however the complex fermentation medium may comprise a compound selected from the group consisting of lactose, nutrients, vitamins tryptone, soy peptone, yeast extract, ascorbic acid, magnesium sulfate, milk and combinations thereof.
[0090] In one embodiment, the heme protein is added at a level that allows respiration to be above the natural oxygen consumption level that the cells can support. The heme protein stimulates aerobic microbial growth in a dose-dependent manner, such that oxygen consumption, a measure of microbial growth, peaks earlier and at a faster rate than in cultures without the heme protein.
[0091] Thus, in one embodiment, oxygen consumption in the fermentation reaches its maximum in less than 12 hours, such as less than 10 hours or less than 8 hours.
[0092] In one embodiment, the oxygen consumption in the fermentation reaches 0.04 mol O2 / L / h in less than 10 hours or less than 8 hours.
[0093] Oxygen consumption can be measured using any method known to those skilled in the art.
[0094] In one embodiment, the culture medium in step (i) comprises before fermentation (i.e. before the addition of at least one microbial strain) at least 0.5% w / w of at least one hemoglobin protein by weight of the culture medium (i.e. before the addition of at least one microbial strain), for example 1% w / w, for example 2% w / w, for example 3% w / w, for example 4% w / w, for example in the range of 0.5-4% w / w, for example 1-3.5% w / w, for example 1.5-3% w / w, for example 2-2.5% w / w of at least one hemoglobin protein strain.
[0095] In another embodiment, the culture medium in step (i) comprises a microbial inoculum culture (such as a lactic acid bacteria inoculum culture) of at least 0.5% w / w of the culture medium weight before fermentation (i.e., before adding at least one microbial strain), for example at least 1% w / w before fermentation, for example 1.5% w / w, for example 2% w / w, for example 2.5% w / w, for example 3% w / w, for example 3.5% w / w, for example 4% w / w, for example in the range of 0.5-4% w / w, for example 1-3.5% w / w, for example 1.5-3% w / w, for example 2-2.5% w / w of the lactic acid bacteria inoculum culture. The inoculation culture can be carried out according to the method specified in Example 1.
[0096] In a preferred embodiment, the heme protein is added to a concentration of about 0.1 g / kg to about 10 g / kg of fermentation.
[0097] Surprisingly, by the method of the present invention, it is sometimes possible to obtain sufficiently concentrated microbial cultures, such as lactic acid bacteria cultures, for use in the production of F-DVS without concentrating the culture. However, even when the present method is applied, most cultures require concentration to obtain starter cultures of commercial interest. Such cultures are preferably harvested and concentrated by centrifugation or ultrafiltration.
[0098] Furthermore, a preferred embodiment is one in which the cultivation is carried out in a large fermenter containing 5 L to 100.000 L of culture medium, preferably 300 L to 20.000 L of culture medium.
[0099] A preferred embodiment is wherein the culturing comprises controlling temperature and / or pH.
[0100] In one embodiment, the culture medium in step (i) and / or step (ii) comprises one or more microbial strains which are microbial strains that are unable to grow respiratoryly without supplementation of components / replacement components of the respiratory chain.
[0101] In one embodiment, the culture medium in step (i) and / or step (ii) comprises at least one microbial strain selected from the group consisting of: Lactococcus, Streptococcus, Lactobacillus (now known as Ligilactobacillus), Holzapfelia, Amylolactobacillus, Bombilactobacillus, Companilactobacillus, Lapidilactobacillus, Agrilactobacillus, Schleiferilactobacillus, Loigolactobacilus, Lacticaseiba cillus, Latilactobacillus, Dellaglioa, Liquidilactobacillus, Lactiplantibacillus, Furfurilactobacillus, Paucilactobacillus, Limosilactobacillus, Fructilactobacillus, Acetilactobacillus, Apilactobacillus, Levilactobacillus, Secundilactobacillus, and Lactobacillus lentus (e.g., Zheng et al., Int. J. Syst. Evol. Microbiol. DOI: 10.1016 / 0300-9444-0100). 10.1099 / ijsem.0.004107), Leuconostoc, Oenococcus, Weissella, Pediococcus, Enterococcus, Bifidobacterium, Brevibacterium, Propionibacterium, and combinations thereof.
[0102] In an embodiment, the culture medium in step (i) and / or step (ii) comprises at least one lactic acid bacterium selected from the group consisting of: Lactococcus, Streptococcus, Lactobacillus (now known as Ligilactobacillus), Holzapfelia, Amylolactobacillus, Bombilactobacillus, Companilactobacillus, Lapidilactobacillus, Agrilactobacillus, Schleiferilactobacillus, Loigolactobacilus, Lacticaseibacillus, Latilactobacillus, acillus), Dellaglioa, Liquidilactobacillus, Ligilactobacillus, Lactiplantibacillus, Furfurilactobacillus, Paucilactobacillus, Limosilactobacillus, Fructilactobacillus, Acetilactobacillus, Apilactobacillus, Levilactobacillus, Secundilactobacillus, and Lentilactobacillus (e.g., Zheng et al., Int. J. Syst. Evol. Microbiol. DOI: 10.1016 / 0300-9444-0100). 10.1099 / ijsem.0.004107), Leuconostoc, Oenococcus, Weissella, Pediococcus, and Enterococcus.
[0103] In an embodiment, the culture medium in step (i) and / or step (ii) comprises one or more mesophilic organisms selected from the group comprising: Lactococcus lactis, Lactococcus lactis subsp. cremoris, Leuconostocmesenteroides subsp. cremoris, Pediococcus pentosaceus, Lactococcus lactis subsp. lactis biovar. diacetylactis, Lactobacillus casei subsp. casei (new name Lacticaseibacillus casei), Lactobacillus paracasei subsp. casei (Lactococcus paracasei subsp. casei and Lactococcus paracasei subsp. tolerans) and Oenococcus oeni.
[0104] In further embodiments, the culture medium in step (i) and / or step (ii) comprises one or more thermophilic organisms having an optimal growth temperature of about 40°C to about 45°C.
[0105] In yet another embodiment, the culture medium in step (i) and / or step (ii) comprises one or more thermophilic organisms selected from the group comprising Streptococcus thermophilus, Enterococcus faecium, Lactobacillus delbrueckii subsp. lactis, Lactobacillus helveticus, Lactobacillus delbrueckii subsp. bulgaricus and Lactobacillus acidophilus.
[0106] In an embodiment, the culture medium in step (i) and / or step (ii) is a LD-culture comprising one or more organisms selected from the group comprising: Lactococcus lactis subsp. lactis, Lactococcus lactis subsp. cremoris, Lactococcus lactis subsp. lactis biovar. diacetylactis and Leuconostoc mesenteroides subsp. cremoris. In the present context, the term "LD-culture" is to be understood as a combination of the species Lactococcus lactis and the species Leuconostoc.
[0107] It is understood that the culture medium in step (i) and / or step (ii) is an O-culture, which comprises one or more organisms selected from the group comprising Lactococcus lactis subsp. lactis and Lactococcus lactis subsp. cremoris. In this article, "O-culture" is understood to be a culture medium comprising Lactococcus lactis subsp. lactis and Lactococcus lactis subsp. cremoris. O-cultures are commonly used to make non-porous cheeses (cheddar cheese, Chesh-ire, Feta). This specific culture can be purchased from Chr. Hansen, Denmark, under the name of R604 (catalog number 200113).
[0108] In a preferred embodiment, the culture medium in step (i) and / or step (ii) is a culture comprising Lactococcus lactis.
[0109] To obtain maximum yield, it may be preferred to perform the harvesting in step (ii) between 5 and 24 hours after the start of the culture.
[0110] The method of the present invention may further comprise preserving the harvested microbial culture or lactic acid bacteria culture obtained in step (ii) or the concentrated microbial culture or lactic acid bacteria culture obtained in step (iii).
[0111] Due to the high yield of the method, the microbial culture in the fermentation obtained in step (i) may contain a range of 2.0E+10-5.0E+10 active microbial cells / g microbial culture, such as 2.5E+10-4.5E+10, such as 3.0E+10–4.0E+10 active microbial cells / g microbial culture. Similarly, the microbial culture in the fermentation obtained in step (i) may contain a range of 2.0E+10-5.0E+10 total microbial cells / g microbial culture, such as 2.5E+10-4.5E+10, such as 3.0E+10–4.0E+10 total microbial cells / g microbial culture. It can be seen from Table 2 of the experimental part that the number of active lactic acid bacteria cells is almost the same as the total number of lactic acid bacteria cells, indicating that the lactic acid bacteria culture and lactic acid bacteria starter culture obtained by the present invention have high vitality.
[0112] Due to the high yield of the method, the lactic acid bacteria culture in the fermentation obtained in step (i) may contain a range of 2.0E+10-5.0E+11 active lactic acid bacteria cells / g lactic acid bacteria culture, such as 2.5E+10–4.5E+10, for example 3.0E+10–4.0E+10 active lactic acid bacteria cells / g lactic acid bacteria culture. Similarly, the lactic acid bacteria culture in the fermentation obtained in step (i) may contain 2.0E+10-5.0E+10 total lactic acid bacteria cells / g acidic bacteria culture, for example 2.5E+10–4.5E+10, for example 3.0E+10–4.0E+10 total lactic acid bacteria cells / g acidic bacteria culture. It can be seen from Table 2 of the experimental part that the number of active lactic acid bacteria cells is almost the same as the total number of lactic acid bacteria cells, indicating that the lactic acid bacteria culture and lactic acid bacteria starter culture obtained by the present invention have high vitality.
[0113] The number of viable cells and / or total cells is determined using flow cytometry using techniques known to those skilled in the art.
[0114] In a preferred embodiment, the increased yield of one or more microbial strains (e.g., lactic acid bacteria) or microbial cultures (e.g., lactic acid bacteria cultures) harvested by the method is increased by at least 1.2 times, preferably at least 1.3 times, more preferably at least 1.4 times, even more preferably at least 1.5 times, and most preferably at least 1.6 times, compared to an anaerobic process that does not include a heme source process.
[0115] In a second aspect, the present invention relates to a microbial culture, such as a starter culture, obtainable by the method of the first aspect of the present invention.The microbial culture, such as a starter culture, may be provided as a culture concentrate, such as a starter culture concentrate.
[0116] In a third aspect, the present invention is directed to a microbial culture, such as a starter culture, comprising at least one heme protein.
[0117] A fourth aspect relates to a culture medium comprising at least one heme protein.
[0118] A fifth aspect of the present invention relates to a method for preparing a food, feed product, pharmaceutical, dairy flavoring and cheese flavoring product, the method comprising adding an effective amount of a culture according to the second or third aspect to a food, feed or pharmaceutical starting material and maintaining the inoculated culture under conditions where at least one microbial strain is metabolically active.
[0119] Preferably, the food product of the fifth aspect of the present invention is selected from the group consisting of: dairy-based products, vegetable products, meat products, beverages, juices, wines, bakery products, dairy flavorings and cheese flavorings.
[0120] Preferably, the dairy based product is selected from the group consisting of cheese, yoghurt, butter, inoculated sweet milk and liquid fermented dairy products.
[0121] In a sixth aspect, the present invention relates to a fermented food, feed or pharmaceutical product obtainable by the method of the first aspect.
[0122] A seventh aspect of the present invention relates to the use of at least one heme protein in a fermentation method and / or a fermentation process.
[0123] The compounds produced by microorganisms include, but are not limited to, enzymes, proteins, metabolites, glycolipids, antibiotics, bacteriocins, amino acids, flavoring agents, volatiles. Such compounds can be produced by recombinant DNA technology or by conventional methods.
[0124] An eighth aspect relates to a food, feed product, pharmaceutical product, dairy flavouring or cheese flavouring product comprising the culture according to the second or third aspect.
[0125] The invention is further illustrated in the following non-limiting examples and figures. BRIEF DESCRIPTION OF THE DRAWINGS
[0126] Figure 1 . A graph showing oxygen transfer rates according to an embodiment of the present invention.
[0127] Example
[0128] Example 1: Fermentation using catalase as heme protein in a complex fermentation medium from Chr. Hansen A / S
[0129] Prepare catalase at a concentration of 24%-55% (w / w) in water ( Purchased from NovoZymes) stock solution.
[0130] The catalase solution was then treated at ultra high temperature (UHT) at 141°C for 8-10 seconds to sterilize the material and completely inactivate the enzyme.
[0131] product Contains 9% w / w catalase and 42% w / w sorbitol. Surprisingly, sorbitol was found to act as a protein stabilizer. When the heme molecules were in solution, they degraded at high temperatures and were no longer able to support the respiration of Lactococcus lactis (data not shown).
[0132] Thus, sorbitol acts as a protein stabilizer and heme protector.
[0133] Culture
[0134] The experiments were performed using a commercially available culture of Lactococcus lactis, deposited under the number DSM 24648 by Chr. Hansen AG (Horsholmsholm, Denmark) at DSMZ - German Collection of Microorganisms, Inhofenstrasse 7B D-38124, Braunschweig. on March 15, 2011.
[0135] Fermentation medium
[0136] The fermentation medium used is Chr. Hansen’s proprietary vegetarian-friendly complex fermentation medium.
[0137] Negative control
[0138] Anaerobic co-fermentation medium was used as negative control medium. This medium is Chr. Hansen's proprietary vegetarian-friendly co-fermentation medium without heme source.
[0139] Positive Control
[0140] Aerobic co-fermentation medium was used as a positive control medium. This medium is Chr. Hansen's proprietary vegetarian-friendly co-fermentation medium that includes a non-vegetarian heme source.
[0141] The medium was sterilized by UHT treatment (141°C, 8-10 seconds). The pH value of the finished medium was 6.5.
[0142] Fermentation conditions of the culture
[0143] 1% (w / w) of the above culture was used as inoculum and the above heme protein As a heme source, fermentations were performed in 2L lab-scale fermenters at 30°C with aeration. For aerobic fermentation as a positive control, the same conditions as for aerobic fermentation were applied with aeration in Chr. Hansen's proprietary vegetarian-friendly complex fermentation medium including a non-vegetarian heme source. For anaerobic fermentation as a negative control, the same conditions as for aerobic fermentation were applied, but without aeration in Chr. Hansen's proprietary vegetarian-friendly complex fermentation medium excluding a heme source. The culture was acidified to pH 6.0. The pH was subsequently maintained at 6.0 by the controlled addition of 27% NH4OH.
[0144] When no further basal consumption was detected, the respective cultures were cooled to about 10°C.
[0145] After cooling, the bacteria in the culture medium were concentrated 6-18 times by centrifugation and subsequently frozen into pellets in liquid nitrogen at 1 atmosphere to produce so-called frozen direct-dose cultures (F-DVS). F-DVS pellets were stored at –50°C until further analysis.
[0146] Process parameter evaluation
[0147] Lactococcus lactis profoundly changes metabolism when it switches from anaerobic to respiratory growth. Biomass approximately doubles and acid production decreases during respiratory growth compared to anaerobic growth. The key characteristic of respiratory growth is the reduction in dissolved oxygen (DO%). Figure 1 ). Compared with the aerobic positive control, the (heme protein, 9% w / w) showed similar dissolved oxygen (DO%).
[0148] In short, according to Figure 1 In the process curve, use As a positive control for the respiratory fermentation of heme proteins and aerobic fermentation ( Figure 1 , non-vegetarian heme sources) are just as good to support respiratory growth.
[0149] Downstream process assessment
[0150] After fermentation, the fermentation is tested for packed cell volume (PCV) (centrifugation of the fermentation in special centrifuge tubes). This is the first indication of the biomass. The PCV test shows that the Fermentation produced approximately the same levels of bacterial cells in PCV as the aerobic positive control process, whereas the anaerobic negative control resulted in lower PCV levels (data not shown).
[0151]
[0152] To be filled in by the receiving office
[0153]
[0154] To be filled in by the International Bureau
[0155]
Claims
1. A method for obtaining a microbial culture, the method comprising the following steps: (i) cultivating at least one microbial strain in a culture medium under aeration and obtaining a fermentation product, (ii) harvesting the microbial strain from the fermentation product to obtain the microbial culture, wherein the culture medium comprises at least one heme protein.
2. The method according to claim 1, wherein the heme protein is a protein having natural biocatalytic activity.
3. The method of claim 2, wherein the heme protein is an enzyme.
4. The method of claim 1, wherein the heme protein is a protein that has no native biocatalytic activity.
5. A method according to any one of the preceding claims, wherein the oxygen consumption in the fermentation reaches 0.04 mol O2 / L / h in less than 10 hours or less than 8 hours.
6. The method according to any one of the preceding claims, wherein the heme protein is produced by a microorganism.
7. The method of any one of the preceding claims, wherein the heme protein is produced by expression of Aspergillus, Pichia, Bacillus or Escherichia.
8. The method of claim 7, wherein the heme protein is catalase or peroxidase.
9. The method of any one of the preceding claims, wherein the heme protein is added at a concentration of about 0.1 g / kg to about 10 g / kg fermentate.
10. The method according to any one of the preceding claims, further comprising: (iii) concentrating the microbial culture to obtain a concentrated microbial culture.
11. The method according to any one of the preceding claims, further comprising: (iv) freezing or drying the microbial culture to obtain a frozen microbial culture or a dried microbial culture.
12. The method according to claim 10 or 11, further comprising: (v) packaging the frozen microbial culture or the dried microbial culture obtained in step (iv).
13. The method according to any one of claims 2 or 3, wherein the hemoglobin protein is an inactivated hemoglobin protein.
14. The method of claim 13, wherein the heat-inactivated heme protein is heat-inactivated.
15. The method according to any one of the preceding claims, wherein the culture medium does not contain non-vegetarian compliant heme proteins.
16. A method according to any one of the preceding claims, wherein the heme protein is catalase, e.g.
17. The method according to any one of the preceding claims, wherein the culture medium further comprises a thermostable compound selected from the group consisting of polyols, sugars, biopolymers, amino acids, salts, polymers and non-ionic detergents.
18. The method of claim 17, wherein the heat-stable compound is selected from the group consisting of sorbitol, glycerol, propylene glycol, mannitol, xylitol, propylene glycol, trehalose, sucrose, lactose, maltose, glucose, fructan (fructose homopolysaccharide), dextran, dextran sulfate, gelatin (type A and type B), hydroxyethyl starch, poly-L-glutamic acid, poly-L-lysine, fucoidan, pentosan polysulfate, keratan sulfate, polyaspartate, poly Glutamate, hydroxyethylcellulose, hydroxypropyl-β-cyclodextrin, glycine, L-arginine hydrochloride, arginine, proline, lysine, histidine, aspartic acid, glutamic acid, acetate, citrate, sodium chloride, phosphate, ascorbate, polyacrylic acid (A8-35) randomly modified with n-octylamine and isopropylamine, polyethylene glycol (PEG), polyvinyl sulfate, polysorbate 20, polysorbate 80, TritonX-100, Pluronic F68, Pluronic F88, Pluoronic F-127, Brij 35 (polyoxyethylene alkyl ether).
19. A culture obtainable by the method according to any one of claims 1 to 18.
20. A culture or medium comprising at least one heme protein.
21. The culture or medium of claim 20, wherein the heme protein is catalase.
22. The culture or medium of claim 21, further comprising a thermostable compound selected from the group consisting of polyols, sugars, biopolymers, amino acids, salts, polymers and non-ionic detergents.
23. The culture or medium of claim 22, wherein the heat stable compound is selected from the group consisting of: sorbitol, glycerol, propylene glycol, mannitol, xylitol, propanediol, trehalose, sucrose, lactose, maltose, glucose, fructan (fructose homopolysaccharide), dextran, dextran sulfate, gelatin (type A and type B), hydroxyethyl starch, poly-L-glutamic acid, poly-L-lysine, fucoidan, pentosan polysulfate, keratan sulfate Salt, polyaspartate, polyglutamate, hydroxyethylcellulose, hydroxypropyl-β-cyclodextrin, glycine, L-arginine hydrochloride, arginine, proline, lysine, histidine, aspartic acid, glutamic acid, acetate, citrate, sodium chloride, phosphate, ascorbate, polyacrylic acid randomly modified with n-octylamine and isopropylamine (A8-35), polyethylene glycol (PEG), polyvinyl sulfate, polysorbate 20, polysorbate 80, Triton X-100, Pluronic F68, Pluronic F88, Pluoronic F-127, Brij 35 (polyoxyethylene alkyl ether).
24. A method for preparing a food, feed product, pharmaceutical product, dairy flavoring and cheese flavoring product, the method comprising adding an effective amount of a culture according to any one of claims 19 to 23 to a starting material of a food, feed product or pharmaceutical product and maintaining the inoculated culture under conditions where the at least one microbial strain is metabolically active.
25. A fermented food, feed product or pharmaceutical product obtainable by the method according to any one of claims 1-18.
26. Use of at least one heme protein in a fermentation method and / or a fermentation process.
27. A food, feed product, pharmaceutical product, dairy flavouring or cheese flavouring product comprising the culture according to any one of claims 19 to 23.
